More and more drugs are voluntarily recovered due to the excessive detection of impurities AZBT(Azido Methyl Bipheny Ttetrazole).

On the 6th, the recovery of items produced before 2021 among three items containing Irvesartan (Rovelito, CoAprovel, and Arovel) was decided, and AZBT was also detected in a Valsartan compound produced by a domestic pharmaceutical company.

The results of the AZBT detection test for the finished product containing Sartan shall be submitted to the MFDS by the end of this month. The voluntary recovery of AZBT-exceeded pharmaceutical companies will continue. According to an industry on the 24th, AZBT detection exceeded the standard and related items began to voluntari